BDNF concentration and impulsiveness level in post-traumatic stress disorder

Psychiatry Research

Volumn 229, Issue 3, 2015, Pages 814-818

  Martinotti, Giovanni ^a   Sepede, Gianna ^a,b   Brunetti, Marcella ^a   Ricci, Valerio ^c   Gambi, Francesco ^a   Chillemi, Eleonora ^a   Vellante, Federica ^a   Signorelli, Maria ^d   Pettorruso, Mauro ^e   De Risio, Luisa ^e   Aguglia, Eugenio ^d   Angelucci, Francesco ^c   Caltagirone, Carlo ^c   Di Giannantonio, Massimo ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

Author keywords

BDNF; Impulsiveness; Post traumatic stress disorder; Trauma exposure

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ARTICLE; BARRATT IMPULSIVENESS SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSIVENESS; MALE; MOLECULAR PATHOLOGY; POSTTRAUMATIC STRESS DISORDER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; PSYCHOTRAUMA; BEHAVIOR ASSESSMENT; BLOOD; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY;

ADULT; BEHAVIOR RATING SCALE; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84941261527     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2015.07.085     Document Type: Article

References (59)

1. Alderson R.F., Alterman A.L., Barde Y.A., Lindsay R.M. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron 1990, 5:297-306.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Text Revision 2000, American Psychiatric Press, Washington, DC. 4th ed.
3. Angelucci F., Ricci V., Gelfo F., Martinotti G., Brunetti M., Sepede G., Signorelli M., Aguglia E., Pettorruso M., Vellante F., Di Giannantonio M., Caltagirone C. BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. Brain Cogn. 2014, 84(1):118-122.
4. Angelucci F., Martinotti G., Gelfo F., Righino E., Conte G., Caltagirone C., Bria P., Ricci V. Enhanced BDNF serum levels in patients with severe pathological gambling. Addict. Biol. 2013, 18(4):749-751.
5. Angelucci F., Ricci V., Martinotti G., Palladino I., Spalletta G., Caltagirone C., Bria P. Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. Addict. Biol. 2010, 15(3):365-367.
6. Archer T., Oscar-Berman M., Blum K., Gold M. Neurogenetics and epigenetics in impulsive behaviour: impact on reward circuitry. J. Genet. Syndr. Gene Ther. 2012, 3(3):1000115.
7. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Gusman F.D., Charney D.S., Keane T.M. The development of a Clinician-Administered PTSD Scale. J. Trauma. Stress 1995, 8(1):75-90.
8. Bonne O., Gill J., Luckenbaugh D., Owens M., Alesci S., Neumeister A., Yuan P., Kinkead B., Manji H.K., Charney D.S., Vythilingam M. Corticotropin-releasing factor, interleukin-6, brainderived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine. J. Clin. Psychiatry 2011, 72:1124-1128.
9. Bremner J.D., Randall P., Vermetten E., Staib L., Bronen R.A., Mazure C., Capelli S., McCarthy G., Innis R.B., Charney D.S. Magnetic resonance imaging-based measurement of hippocampal volume inposttraumatic stress disorder related to childhood physical and sexual abuse-a preliminary report. Biol. Psychiatry 1997, 41(1):23-32.
10. Bremner J.D., Vythilingam M., Vermetten E., Southwick S.M., McGlashan T., Nazeer A., Khan S., Vaccarino L.V., Soufer R., Garg P.K., Ng C.K., Staib L.H., Duncan J.S., Charney D.S. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am. J. Psychiatry 2003, 160(5):924-932.
11. Brunetti M., Sepede G., Mingoia G., Catani C., Ferretti A., Merla A., Del Gratta C., Romani G.L., Babiloni C. Elevated response of human amygdala to neutral stimuli in mild post traumatic stress disorder: neural correlates of generalized emotional response. Neuroscience 2010, 168(3):670-679.
12. Chen S.L., Lee S.Y., Chang Y.H., Chen S.H., Chu C.H., Wang T.Y., Chen P.S., Lee I.H., Yang Y.K., Hong J.S., Lu R.B. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2014, 51:99-104.
13. Cicolini G., Simonetti V., Comparcini D., Galli F., Di Labio L., Mercanti R., Sepede G. Impulsivity in inpatient substance abusers: an exploratory study. J. Clin. Nurs. 2014, 23(5-6):896-899.
14. Cloninger C.R. A systematic method for clinical description and classification of personality variants. Arch. General Psychiatry 1987, 44:573-588.
15. Connor B., Dragunow M. The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res. Rev. 1998, 27(1):1-39.
16. Cunha A.B., Frey B.N., Andreazza A.C., Goi J.D., Rosa A.R., Goncalves C.A., Santin A., Kapczinski F. Serum brain derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 2006, 398(3):215-219.
17. Daruna J.H., Barnes P.A. A neurodevelopmental view of impulsivity. The Impulsive Client: Theory, Research, and Treatment 1993, American Psychological Association, Washington, DC. W.G. McCown, J.L. Johnson, M.B. Shure (Eds.).
18. Dell'osso L., Carmassi C., Del Debbio A., Dell'osso M.C., Bianchi C., da Pozzo E., Origlia N., Domenici L., Massimetti G., Marazziti D., Piccinni A. Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2009, 33:899-902.
19. Deltheil T., Guiard B.P., Cerdan J., David D.J., Tanaka K.F., Repérant C., Guilloux J.P., Coudoré F., Hen R., Gardier A.M. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 2008, 55(6):1006-1014.
20. Di Nicola M., Tedeschi D., De Risio L., Pettorruso M., Martinotti G., Ruggeri F., Swierkosz-Lenart K., Guglielmo R., Callea A., Ruggeri G., Pozzi G., Di Giannantonio M., Janiri L. Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving. Drug Alcohol Depend. 2015, 148:118-125.
21. Evenden J. Impulsivity: a discussion of clinical and experimental findings. J. Psychopharmacol. 1999, 13(2):180-192.
22. First M.B., Spietzer R.L., Gibbon M., William J.B.W. Structured Clinical Interview for DSM-1V Axis 1 Disorders Clinical Version 1997, American Psychiatric Press, Washington, DC.
23. García-Forero C., Gallardo-Pujol D., Maydeu-Olivares A., Andrés-Pueyo A. Disentangling impulsiveness, aggressiveness and impulsive aggression: an empirical approach using self-report measures. Psychiatry Res. 2009, 168(1):40-49.
24. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science 1994, 263:1618-1623.
25. Ha D.H., Robertson R.T., Roshanaei M., Weiss J.H. Enhanced survival and morphological features of basal forebrain cholinergic neurons in vitro: role of neurotrophins and other potential cortically derived cholinergic trophic factors. J. Comp. Neurol. 1999, 406(2):156-170.
26. Hauck S., Kapczinski F., Roesler R., de Moura Silveira E., Magalhaes P.V., Kruel L.R., Schestatsky S.S., Ceitlin L.H. Serum brain-derived neurotrophic factor in patients with trauma psychopathology. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2010, 34:459-462.
27. Homberg J.R., Molteni R., Calabrese F., Riva M.A. The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology. Neurosci. Biobehav. Rev. 2014, 43:35-47.
28. Hughes K.C., Shin L.M. Functional neuroimaging studies of post-traumatic stress disorder. Expert Rev. Neurother. 2011, 11(2):275-285.
29. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991, 350:230-232.
30. Iasevoli F., Valchera A., Di Giovambattista E., Marconi M., Rapagnani M.P., De Berardis D., Martinotti G., Fornaro M., Mazza M., Tomasetti C., Buonaguro E.F., Di Giannantonio M., Perugi G., de Bartolomeis A. Affective temperaments are associated with specific clusters of symptoms and psychopathology: a cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. J. Affect. Disord. 2013, 151(2):540-550.
31. James L.M., Strom T.Q., Leskela J. Risk-taking behaviors and impulsivity among veterans with and without PTSD and mild TBI. Mil. Med. 2014, 179(4):357-363.
32. Keane T.M., Marshall A.D., Taft C.T. Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Annu. Rev. Clin. Psychol. 2006, 2:161-197.
33. Keilp J.G., Sackeim H.A., Mann J.J. Correlates of trait impulsiveness in performance measures and neuropsychological tests. Psychiatry Res. 2005, 135(3):191-201.
34. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H., Lee S.W., Yoon D., Han C., Kim D.J., Choi S.H. Low plasma BDNF is associated with suicidal behaviour in major depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2007, 31(1):78-85.
35. Laske C., Stellos K., Hoffmann N., Stransky E., Straten G., Eschweiler G.W., Leyhe T. Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. Int. J. Neuropsychopharmacol. 2011, 14(3):399-404.
36. Liberzon I., Sripada C.S. The functional neuroanatomy of PTSD: a critical review. Prog. Brain Res. 2007, 167:151-169.
37. Lindholm D., Carroll P., Tzimagiogis G., Thoenen H. Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3, and NT-4. Eur. J. Neurosci. 1996, 8:1452-1460.
38. Mandelli L., Mazza M., Martinotti G., Tavian D., Colombo E., Missaglia S., Di Nicola M., De Ronchi D., Negri G., Colombo R., Janiri L., Serretti A. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. J. Psychopharmacol. 2010, 12:1747-1754.
39. Martinotti G., Di Iorio G., Marini S., Ricci V., De Berardis D., Di Giannantonio M. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review. J. Biol. Regul. Homeost. Agents 2012, 3:347-356.
40. Martinotti G., Lupi M., Acciavatti T., Cinosi E., Santacroce R., Signorelli M.S., Bandini L., Lisi G., Quattrone D., Ciambrone P., Aguglia A., Pinna F., Calò S., Janiri L., di Giannantonio M. Novel psychoactive substances in young adults with and without psychiatric comorbidities. BioMed. Res. Int. 2014, (ID 815424).
41. Martinotti G., Ricci V., Di Nicola M., Caltagirone C., Bria P., Angelucci F. Brain-derived neurotrophic factor and electroconvulsive therapy in a schizophrenic patient with treatment-resistant paranoid-hallucinatory symptoms. J. ECT 2011, 27(1):e44-e46.
42. Mercader J.M., Fernández-Aranda F., Gratacòs M., Ribasés M., Badía A., Villarejo C., Solano R., González J.R., Vallejo J., Estivill X. Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients. Neuropsychobiology 2007, 56:185-190.
43. Minelli A., Zanardini R., Bonvicini C., Sartori R., Pedrini L., Gennarelli M., Bocchio-Chiavetto L. BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:323-329.
44. Newport D.J., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. Curr. Opin. Neurobiol. 2000, 2:211-218.
45. Park Y.M., Lee B.H., Um T.H., Kim S. Serum BDNF levels in relation to illness severity, suicide attempts, and central serotonin activity in patients with major depressive disorder: a pilot study. PLoS One 2014, 9(3):e91061.
46. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 1995, 51(6):768-774.
47. Qureshi S.U., Long M.E., Bradshaw M.R., Pyne J.M., Magruder K.M., Kimbrell T., Hudson T.J., Jawaid A., Schulz P.E., Kunik M.E. Does PTSD impair cognition beyond the effect of trauma?. J. Neuropsychiatry Clin. Neurosci. 2011, 23(1):16-28.
48. Ricci V., Martinotti G., Gelfo F., Tonioni F., Caltagirone C., Bria P., Angelucci F. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berlin) 2011, 215(1):143-148.
49. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64(6):527-532.
50. Shim S.H., Hwangbo Y., Kwon Y.J., Jeong H.Y., Lee B.H., Lee H.J., Kim Y.K. Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2008, 32(8):1824-1828.
51. Spalletta G., Morris D.W., Angelucci F., Rubino I.A., Spoletini I., Bria P., Martinotti G., Siracusano A., Bonaviri G., Bernardini S., Caltagirone C., Bossù P., Donohoe G., Gill M., Corvin A.P. BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia. Eur. Psychiatry 2010, 25(6):311-313.
52. Stevens J.S., Jovanovic T., Fani N., Ely T.D., Glover E.M., Bradley B., Ressler K.J. Disrupted amygdala-prefrontal functional connectivity in civilian women with posttraumatic stress disorder. J. Psychiatr. Res. 2013, 47(10):1469-1478.
53. Teixeira A.L., Bretas T.L., Kummer A., Melo L.C., Baraldi A., Harsányi E., Cardoso F., da Silva Camargos E.R. Serum levels of brain-derived neurotrophic factor in Sydenham's chorea. Neurol. Sci. 2010, 31(3):399-401.
54. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270(5236):593-598. (Review).
55. Uher R. Gene-environment interactions in severe mental illness. Front. Psychiatry 2014, 5:48.
56. Weiss N.H., Tull M.T., Anestis M.D., Gratz K.L. The relative and unique contributions of emotion dysregulation and impulsivity to posttraumatic stress disorder among substance dependent inpatients. Drug Alcohol Depend. 2013, 128(1-2):45-51.
57. Zhang H., Ozbay F., Lappalainen J., Kranzler H.R., van Dyck C.H., Charney D.S., Price L.H., Southwick S., Yang B.Z., Rasmussen A., Gelernter J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. Part B: Neuropsychiatr. Genet. 2006, 141B:387-393.
58. Zhang L., Zhou R., Li X., Ursano R.J., Li H. Stress-induced change of mitochondria membrane potential regulated by genomic and non-genomic GR signaling: a possible mechanism for hippocampus atrophy in PTSD. Med. Hypotheses 2006, 66(6):1205-1208.
59. Zhen Y.F., Zhang J., Liu X.Y., Fang H., Tian L.B., Zhou D.H., Kosten T.R., Zhang X.Y. Low BDNF is associated with cognitive deficits in patients with type 2 diabetes. Psychopharmacology (Berlin) 2013, 227(1):93-100.